Hodgkin's Disease

Edith A. Perez, Seth A. Rosenthal, Vincent T. Devita, Susan Molloy Hubbard

Research output: Contribution to journalLetter

Abstract

To the Editor: In their review of drug therapy for Hodgkin's disease (Feb. 25 issue),1 DeVita and Hubbard cite two trials conducted to compare chemotherapy alone with radiotherapy alone as treatment for stage I or II Hodgkin's disease2,3. They stated that both trials demonstrated that “combination therapy was as effective as radiotherapy.” The overall survival in the study by Biti et al.,2 with a median follow-up of eight years, however, was significantly higher among patients treated with radiotherapy than among those treated with chemotherapy (93 percent vs. 56 percent, P<0.001). Furthermore, the survival among patients who relapsed after…

Original languageEnglish (US)
Pages (from-to)361-362
Number of pages2
JournalNew England Journal of Medicine
Volume329
Issue number5
DOIs
StatePublished - Jul 29 1993

ASJC Scopus subject areas

  • Medicine(all)

Fingerprint Dive into the research topics of 'Hodgkin's Disease'. Together they form a unique fingerprint.

  • Cite this

    Perez, E. A., Rosenthal, S. A., Devita, V. T., & Hubbard, S. M. (1993). Hodgkin's Disease. New England Journal of Medicine, 329(5), 361-362. https://doi.org/10.1056/NEJM199307293290515